1 year return (CAGR)
-42.31%
Enlivex Therapeutics Ltd Exchange (NASDAQ, USD)
ENLV
0.61
-0.03 (-5.36%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-30.95%
5 year return (CAGR)
-44.00%
10 year return (CAGR)
-37.44%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
10.59M
Price/Sales
-
Ent value
400.63M
Price/Book
0.01
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
0.01
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 0.64 |
| Daily high | 0.64 |
| Daily low | 0.57 |
| Daily Volume | 371K |
| All-time high | 391.60 |
| 1y analyst estimate | 80.00 |
| Beta | 1.47 |
| EPS (TTM) | 25.63 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 25 Feb 2026 |
Downside potential
Loading...
Downside potential data
| ENLV | S&P500 | |
| Current price drop from All-time high | -99.85% | -1.38% |
| Highest price drop | -99.87% | -56.47% |
| Date of highest drop | 7 Jul 2026 | 9 Mar 2009 |
| Avg drop from high | -88.85% | -10.68% |
| Avg time to new high | 278 days | 12 days |
| Max time to new high | 3037 days | 1805 days |
News
